Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verona Pharma plc

72.73
+0.47000.65%
Post-market: 72.730.00000.00%19:54 EDT
Volume:1.45M
Turnover:105.46M
Market Cap:6.19B
PE:-36.05
High:73.93
Open:72.74
Low:71.19
Close:72.26
Loading ...

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense

MT Newswires Live
·
28 Mar

Verona Pharma Announces Amended Strategic Financing With Oaktree And OMERS

Reuters
·
28 Mar

Press Release: Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Dow Jones
·
28 Mar

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”

Insider Monkey
·
27 Mar

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
10 Mar

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live
·
07 Mar

Verona Pharma plc (VRNA): A Bull Case Theory

Insider Monkey
·
05 Mar

BTIG Sticks to Its Buy Rating for Verona Pharma (VRNA)

TIPRANKS
·
05 Mar

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading

MT Newswires Live
·
04 Mar

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus

Zacks
·
03 Mar

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.
·
02 Mar

Verona Pharma price target raised to $76 from $57 at Truist

TIPRANKS
·
01 Mar

Verona Pharma Is Maintained at Overweight by Wells Fargo

Dow Jones
·
01 Mar

Verona Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Feb

Truist Financial Reaffirms Their Buy Rating on Verona Pharma (VRNA)

TIPRANKS
·
28 Feb

Verona Pharma price target raised to $75 from $60 at H.C. Wainwright

TIPRANKS
·
28 Feb

Verona Pharma Plc : Btig Raises Target Price to $83 From $77

THOMSON REUTERS
·
28 Feb